What partners most often ask when evaluating a full-stack development partner for their synthetic-biology program.
We're your full-stack synthetic biology partner. We carry a program from an engineered organism through a validated, producible bioprocess and pilot-scale material: strain engineering, rapid prototyping, process optimization, and pilot / testing & evaluation-scale production, all under one roof. When you're ready to go bigger, we also help hand off and manage large-scale manufacturing. One accountable partner, from a single cell to commercial scale.
A typical CDMO manufactures to a spec you hand them. We work further upstream as problem-solvers: helping you engineer a viable organism, design for producibility from day one, and de-risk scale-up before you commit significant capital. The goal is a commercially viable end product, not just a batch.
Founders and CEOs of early synthetic-biology companies, and the R&D and scientific leads evaluating a development partner. We're built for teams entering bio-manufacturing who want a single, accountable partner across the journey.
Bench through pilot. Our low-volume production runs at 100 L and under, purpose-built for testing, evaluation, and validation, so you generate scale-representative data without over-committing before a program is ready.
An R&D-grade precision-fermentation facility specializing in BSL-1 microbial hosts, with defined process controls and rigorous analytical reporting.
Our operating framework incorporates GMP-informed documentation practices and controlled process conditions, designed to enable an efficient, clean transition into regulated manufacturing environments as your program advances.
No. We operate as an independent development partner with no competing product interests and no academic mandates. Your program, and its IP, remain yours. Our focus is singular: helping you succeed at scale.
Reach out through our contact page with a short description of your program and stage. We'll follow up to discuss your objectives, evaluate mutual fit, and outline a path forward.